They hypothesized that melanoma metastases acquire expression of the inhibitory FcγRIIB as a decoy receptor to serve as a sink for IgG, as a means to escape FcγR-mediated lysis by antitumor IgG antibodies. The gene discussed is FCGR2B; the disease is melanoma.